Glutathione-degradable drug-loaded nanogel effectively and securely suppresses hepatoma in mouse model

References

• QuailDFJoyceJAMicroenvironmental regulation of tumor progression and metastasisNat Med201319111423143724202395
   PubMed Web of Science ®Google Scholar
• JoyceJAFearonDTT cell exclusion, immune privilege, and the tumor microenvironmentScience20153486230748025838376
   PubMed Web of Science ®Google Scholar
• XuWDingJLiLXiaoCZhuangXChenXAcid-labile boronate-bridged dextran-bortezomib conjugate with up-regulated hypoxic tumor suppressionChem Commun2015513168126815
   Google Scholar
• ShiFDingJXiaoCIntracellular microenvironment responsive PEGylated polypeptide nanogels with ionizable cores for efficient doxorubicin loading and triggered releaseJ Mater Chem201222281416814179
   Web of Science ®Google Scholar
• DingJXuWZhangYSelf-reinforced endocytoses of smart polypeptide nanogels for “on-demand” drug deliveryJ Control Release2013172244445523742879
   PubMed Web of Science ®Google Scholar
• DingJShiFXiaoCOne-step preparation of reduction-responsive poly(ethylene glycol)-poly(amino acid)s nanogels as efficient intracellular drug delivery platformsPolym Chem201121228572864
   Web of Science ®Google Scholar
• MonteroDTachibanaCRahr WintherJAppenzeller-HerzogCIntracellular glutathione pools are heterogeneously concentratedRedox Biol20131150851324251119
   PubMedGoogle Scholar
• DingJChenJLiDBiocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitroJ Mater Chem B2013116981
   Google Scholar
• YaoCTaiZWangXReduction-responsive cross-linked stearyl peptide for effective delivery of plasmid DNAInt J Nanomedicine2015103403341626056440
   PubMed Web of Science ®Google Scholar
• KanapathipillaiMBrockAIngberDENanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironmentAdv Drug Deliv Rev20147980107118
   Google Scholar
• KhorsandBLapointeGBrettCOhJKIntracellular drug delivery nanocarriers of glutathione-responsive degradable block copolymers having pendant disulfide linkagesBiomacromolecules20131462103211123647437
   PubMed Web of Science ®Google Scholar
• DingJShiFXiaoCZhuangXHeCChenXFacile preparation of pH and reduction responsive PEGylated polypeptide nanogel for efficient doxorubicin loading and intracellular deliveryJ Control Release20131721E40E41
   Web of Science ®Google Scholar
• O’ReillyRKHawkerCJWooleyKLCross-linked block copolymer micelles: functional nanostructures of great potential and versatilityChem Soc Rev200635111068108317057836
   PubMed Web of Science ®Google Scholar
• HuoMYuanJTaoLWeiYRedox-responsive polymers for drug delivery: from molecular design to applicationsPolym Chem20145515191528
   Google Scholar
• LiYLokitzBSArmesSPMcCormickCLSynthesis of reversible shell cross-linked micelles for controlled release of bioactive agentsMacromolecules200639827262728
   Web of Science ®Google Scholar
• KooANLeeHJKimSEDisulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug deliveryChem Commun20084865706572
   Google Scholar
• WeiRChengLZhengMReduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)–lipoic acid conjugates for triggered intracellular anticancer drug releaseBiomacromolecules20121382429243822746534
   PubMed Web of Science ®Google Scholar
• LiYXiaoKLuoJWell-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel deliveryBiomaterials201132276633664521658763
   PubMed Web of Science ®Google Scholar
• ChengYHeCXiaoCReduction-responsive cross-linked micelles based on PEGylated polypeptides prepared via click chemistryPolym Chem201341338513858
   Google Scholar
• XingTLaiBYeXYanLDisulfide core cross-linked PEGylated polypeptide nanogel prepared by a one-step ring opening copolymerization of N-carboxyanhydrides for drug deliveryMacromol Biosci201111796296921472989
   PubMed Web of Science ®Google Scholar
• DingJShiFLiDChenLZhuangXChenXEnhanced endocytosis of acid-sensitive doxorubicin derivatives with intelligent nanogel for improved security and efficacyBiomater Sci201316633646
   Google Scholar
• XuWDingJXiaoCLiLZhuangXChenXVersatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeuticBiomaterials2015540728625907041
   PubMedGoogle Scholar
• BanzatoABobisseSRondinaMA paclitaxel-hyaluronan bio-conjugate targeting ovarian cancer affords a potent in vivo therapeutic activityClin Cancer Res200814113598360618519794
   PubMed Web of Science ®Google Scholar
• ErnstingMJMurakamiMRoyALiS-DFactors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesJ Control Release2013172378279424075927
   PubMed Web of Science ®Google Scholar
• WangJXuWDingJCholesterol-enhanced polylactide-based stereocomplex micelle for effective delivery of doxorubicinMaterials201581216230
   Google Scholar
• LeeCCGilliesERFoxMEA single dose of doxorubicin-functionalized bowtie dendrimer cures mice bearing C-26 colon carcinomasProc Natl Acad Sci U S A200610345166491665417075050
   PubMed Web of Science ®Google Scholar
• LammersTSubrVUlbrichKSimultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriersBiomaterials200930203466347519304320
   PubMed Web of Science ®Google Scholar
• MirandaCJMakuiHSoaresRJHfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicinBlood200310272574258012805055
   PubMedGoogle Scholar
• MaggeRSDeAngelisLMThe double-edged sword: neurotoxicity of chemotherapyBlood Rev20152929310025445718
   PubMed Web of Science ®Google Scholar
• DEMPKEWCMTargeted therapy for NSCLC–A double-edged sword?Anticancer Res20153552503251225964523
   PubMed Web of Science ®Google Scholar
• DecaudinDPrimary human tumor xenografted models (‘tumorgrafts’) for good management of patients with cancerAnticancer Drugs201122982784121623183
   PubMed Web of Science ®Google Scholar
• DingJXiaoCLiYEfficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactionsJ Control Release2013169319320323247039
   PubMedGoogle Scholar
• BaeYNishiyamaNFukushimaSKoyamaHYasuhiroMKataokaKPreparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacyBioconjugate Chem2005161122130
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNano-carriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• TaniguchiYKawanoKMinowaTSuginoTShimojoYMaitaniYEnhanced antitumor efficacy of folate-linked liposomal doxorubicin with TGF-β type I receptor inhibitorCancer Sci2010101102207221320608940
   PubMedGoogle Scholar
• SunDDingJXiaoCChenJZhuangXChenXpH-responsive reversible PEGylation improves performance of antineoplastic agentAdv Healthc Mater20154684485525645303
   PubMedGoogle Scholar
• AravindLDixitVMKooninEVApoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisonsScience200129155071279128411181990
   PubMedGoogle Scholar
• PorterAGJänickeRUEmerging roles of caspase-3 in apoptosisCell Death Differ1999629910410200555
   PubMed Web of Science ®Google Scholar
• LuCDAltieriDCTanigawaNExpression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomasCancer Res1998589180818129581817
   PubMed Web of Science ®Google Scholar
• GhoshSKYigitMVUchidaMSequence–dependent combination therapy with doxorubicin and a surviving–specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinomaInt J Cancer201413471758176624114765
   PubMedGoogle Scholar
• KawasakiHAltieriDCLuCDToyodaMTenjoTTanigawaNInhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancerCancer Res19985822507150749823313
   PubMed Web of Science ®Google Scholar
• FairbrotherWJAshkenaziADesigner proteins to trigger cell deathCell201415771506150824949963
   PubMedGoogle Scholar
• StormGvan HoeselQGCMde GrootGKopWSteerenbergPAHillenFCA comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl ratCancer Chemother Pharmacol19892463413482791187
   PubMedGoogle Scholar
• LaurellGBagger-SjöbäckDDegeneration of the organ of Corti following intravenous administration of cisplatinActa Otolaryngol199111138918981759575
   PubMedGoogle Scholar
• BucakAOzdemirCUluSInvestigation of protective role of curcumin against paclitaxel-induced inner ear damage in ratsLaryngoscope201512551175118225583134
   PubMedGoogle Scholar
• ChenHRupaDSTomarREastmondDAChromosomal loss and breakage in mouse bone marrow and spleen cells exposed to benzene in vivoCancer Res19945413353335398012977
   PubMedGoogle Scholar
• HommaYTaniguchiKNakazawaMChanges in the immune cell population and cell proliferation in peripheral blood after gemcitabine-based chemotherapy for pancreatic cancerClin Transl Oncol201416333033523860726
   PubMed Web of Science ®Google Scholar
• DasMJainRAgrawalAKThankiKJainSMacromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratioBioconjugate Chem2014253501509
   PubMed Web of Science ®Google Scholar